State Street’s LB Pharmaceuticals LBRX Stock Holding History

State Street’s Portfolio LBRX Stock Details LBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.5M	Buy	602,028 +97,655	+19%	+$2.87M	﹤0.01%	2374
2026 Q1	$12.4M	Buy	504,373 +254,343	+102%	+$5.87M	﹤0.01%	2491
2025 Q4	$5.57M	Buy	+250,030	New	+$4.37M	﹤0.01%	2947

Other funds holding LBRX

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street's LBRX Position: Q2 2026 in Review

State Street increased its LB Pharmaceuticals (LBRX) stake by 19% in Q2 2026, buying an estimated $2.87M and bringing the position to 602,028 shares worth $19.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.

State Street first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

State Street held 602,028 shares of LB Pharmaceuticals worth $19.5M as of Q2 2026.
State Street bought 97,655 LB Pharmaceuticals shares in Q2 2026, an estimated $2.87M.
LB Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2374 holding.
State Street first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.